Persistent idiopathic facial pain, a diagnosis and treatment of challenge. Case report

Raphael de Souza Borges; Durval Campos Kraychete; Emilly Leticia Gusmão Borges; Valmir Machado de Melo Filho

doi:10.5935/2595-0118.20180053

Case Report

Persistent idiopathic facial pain, a diagnosis and treatment of challenge. Case report

Raphael de Souza Borges; Durval Campos Kraychete; Emilly Leticia Gusmão Borges; Valmir Machado de Melo Filho

http://dx.doi.org/10.5935/2595-0118.20180053 BrJP, vol.1, n3, p.279-282, 2018

PDF

SciELO

Downloads: 0

Abstract

BACKGROUND AND OBJECTIVES: Persistent idiopathic facial pain is a chronic disease with neuropathic origin, whose etiology is usually unknown; it is a medical condition that does not respond satisfactorily to drug therapy. It is also a disease with a major impact on patient quality of life and difficult to diagnose. This study aimed to report the diagnosis of a complex, persistent idiopathic facial pain, the pharmacological intervention taken and the adoption of integrative and complementary practices for the management of persistent idiopathic facial, as well as the clinical course and the impact of these actions on the patient’s quality of life.

CASE REPORT: A female patient, 52, diagnosed 06 years ago as a carrier of persistente idiopathic facial pain associated with bruxism and temporomandibular disorders. The patient presented with a complaint of orofacial pain which did not meet the diagnostic criteria for temporomandibular disorders. The patient also presented myofascial and trigeminal neuralgia pain in the left buccal region which emerged after performing a root canal procedure. The therapeutic plan adopted was based on pharmacological therapy with pregabalin (450mg) in combination with venlafaxine hydrochloride (150mg), continuously. As additional measures, weekly acupuncture sessions, therapy sessions with psychologists, including hypnosis and meditation, as well as peripheral nerve and a venous block during crises and botulinum toxin application were applied.

CONCLUSION: The therapeutic plan adopted led to a considerable improvement in the patient’s quality of life, evidenced by the reduction in pain intensity and a decrease in the frequency of painful crises. The need for interdisciplinary monitoring, as it is a multifactorial disease, as well as for the ongoing training of various categories of health professionals involved in the treatment of persistent idiopathic facial, given that it is a complication which is rare and difficult to diagnose, is observed.

Keywords

Atypical facial pain, Chronic pain, Facial pain, Pain, Quality of life

References

Siqueira JTT, Teixeira MJ. Dores Orofaciais: Diagnóstico e Tratamento. 2009.

Teixeira MJ, Siqueira SR. Neuralgias do segmento facial. J Bras Ocl ATM Dor Orof. 2003;3(10):101-10.

Andrade D Ciampi de, Lefaucheur JP, Galhardoni R, Ferreira KS, Paiva AR Brandão, Bor-Seng-Shu E. Subthalamic deep brain stimulation modulates small fiber-dependent sensory thresholds in Parkinsons' disease. Pain. 2002;153(5):1107-13.

Nóbrega JC, Siqueira SR, Siqueira JT, Teixeira MJ. Diferential diagnosis in atypical facial pain: a clinical study. Arq Neuropsiquiatr. 2007;65(2A):256-61.

Woda A, Pionchon P. A unified of concept of idiophatic orofacial pain: clinical features. J Orofac Pain. 1999;13(3):172-85.

Graff-Radford SB, Solberg WK. Atypical odontalgia. J Craniomand Disord. 1992;6(4):260-5.

Persistent Idiopathic Facial Pain (Previously "Atypical Facial Pain"). 2016.

Ramos JL, Peres RS. Protocolo de avaliação psicológica para pacientes oncológicos: uma proposta. Psicol Argum. 2013;31(75):729-37.

Gazi MC, Issy AM, Ávila IP, Sakata RK. Comparison of acupuncture to injection for myofascial trigger point pain. Pain Pract. 2011;11(2):132-8.

Shah JP, Heimur J. New frontiers in the pathophysiology of myofascial pain. Pain Practioner. 2012;22(2):26-34.

Ram S, Teruel A, Kumar S, Clark G. Clinical characteristics and diagnosis of atypical odontalgia: implications for dentists. J Am Dent Assoc. 2009;140(2):223-8.

Vickers ER, Cousins MJ. Neuropathic orofacial in: part 1-prevalence and pathophysiology. Aust Endod J. 2000;26(1):19-26.

Lilly JP, Law AS. Atypical odontalgia misdiagnosed as odontogenic pain: a case report and discussion of treatment. J Endod. 1997;23(5):337-9.

Ram S, Teruel A, Kumar SK, Clark G. Clinical characteristics and diagnosis of atypical odontalgia: implications for dentists. J Am Dent Assoc. 2009;140(2):223-8.

Mellis M, Secci S. Diagnosis and treatment of atypical odontalgia: a review of the literature and two case reports. J Contemp Dent Pract. 2007;8(3):81-9.

Alves Neto O. Dor - Princípios e Prática. 2009.

Wang BC, Liu D, Furnback WE, Bifa F, Dong P, Xie L. The cost-effectiveness of pregabalin versus gabapentin for peripheral neuropathic pain (pNeP) and postherpetic neuralgia (PHN) in China. Pain Ther. 2016;5(1):81-91.

Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain. 2002;3(1):21-7.

Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2002;32(6):443-50.

Shao XM, Shen Z, Sun J, Fang F, Fang JF, Wu YY. Strong manual acupuncture stimulation of "Huantiao" (GB 30) reduces pain-induced anxiety and p-ERK in the anterior cingulate cortex in a rat model of neuropathic pain. Evid Based Complement Alternat Med. 2015;2015:235491.

Portnoi AG. Dor, Stress e Coping: Grupos Operativos em Doentes com Síndrome de Fibromialgia. 1999.

Submitted date:
03/18/2018

Accepted date:
08/01/2018

Persistent idiopathic facial pain, a diagnosis and treatment of challenge. Case report

Raphael de Souza Borges; Durval Campos Kraychete; Emilly Leticia Gusmão Borges; Valmir Machado de Melo Filho

Abstract

Keywords

References

Links

Share

BrJP